8-K: Profusa Inc. Confirms Nasdaq Listing Compliance Post-Reverse Split

Profusa, Inc. announced it has received confirmation from Nasdaq that it complies with the publicly held shares requirement following its recent reverse stock split, ensuring continued trading on the Nasdaq Capital Market.

Summary

• Profusa, Inc. received a notification from Nasdaq on August 26, 2026, stating that the company had fallen below the required 500,000 publicly held shares after its 1-for-4 reverse stock split.
• However, following correspondence on August 21, 2026, Nasdaq has determined that Profusa complies with the Publicly Held Shares Requirement as of August 21, 2026.
• No further action is required by the company regarding this specific requirement.
• The company's common stock will continue to trade on the Nasdaq Global Market under the symbol PFSA.
• This filing is made to comply with Nasdaq Listing Rule 5810(b) for prompt public disclosure.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, as the company has successfully addressed a potential delisting concern and confirmed compliance with Nasdaq's publicly held shares requirement.

Positives

• Profusa, Inc. has successfully addressed and resolved a potential issue with Nasdaq's publicly held shares requirement.
• The company's common stock will continue to be listed and traded on the Nasdaq Capital Market under the symbol PFSA.
• Nasdaq has confirmed compliance as of August 21, 2026, closing its review of this specific rule.

Negatives

• The company initially fell below the minimum requirement of 500,000 publicly held shares following a 1-for-4 reverse stock split.
• The need to file this report indicates a period of concern regarding continued listing on Nasdaq.

Risks

• The company must continue to monitor its compliance with all applicable Nasdaq continued listing requirements.
• Forward-looking statements in the report are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
• Factors detailed in the company's SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2025, could impact future results.

Future Outlook

The company intends to continue monitoring its compliance with all applicable Nasdaq continued listing requirements. The report also contains forward-looking statements regarding potential conversions of notes and the effect of warrant amendments, subject to various risks and uncertainties.

Management Comments

• Profusa, Inc. announced that it has received a letter from Nasdaq stating that the company complies with the Publicly Held Shares Requirement as of August 21, 2026, and no further action is required.
• The company's common stock will continue to trade on the Nasdaq Global Market under the symbol PFSA.

Industry Context

StockSavvy.ai notes that maintaining listing on major exchanges like Nasdaq is critical for companies, especially in the digital health sector, to ensure liquidity, investor confidence, and access to capital. Navigating listing requirements after significant corporate actions like reverse splits is a common challenge.

Stakeholder Impact

• Shareholders: Continued listing on Nasdaq provides liquidity and confidence, preventing potential delisting concerns.
• Investors: The confirmation of compliance alleviates immediate concerns about the stock's trading status.
• The Company: Maintains its status on a major stock exchange, crucial for its reputation and future financial activities.

Next Steps

• Continue to monitor compliance with all applicable Nasdaq continued listing requirements.
• Submit the announcement to Nasdaq's MarketWatch Department as required.

Key Dates

Recommendation

The filing addresses a critical compliance issue, confirming the company's continued listing on Nasdaq. While this resolves an immediate concern, it does not provide new information on the company's core business performance or future growth prospects, suggesting a 'hold' stance pending further operational updates.

Keywords

Nasdaq compliance, Publicly Held Shares Requirement, Reverse Stock Split, Listing Qualifications, Digital Health, Biosensors, Form 8-K